The CD4/CD8 ratio of infused CD19-CAR-T is a prognostic factor for efficacy and toxicity.
Br J Haematol
; 203(4): 564-570, 2023 11.
Article
in En
| MEDLINE
| ID: mdl-37789569
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Lymphoma, Large B-Cell, Diffuse
/
Receptors, Chimeric Antigen
Type of study:
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
Br J Haematol
Year:
2023
Document type:
Article
Affiliation country:
Country of publication: